8-K
filed July 6, 2023, 7:59 PM ET
ticker ALKS
CIK 0001520262
other material
confidence high
sentiment neutral
materiality 0.45
Alkermes shareholders approve 6.5M share increase to equity plan; Sarissa votes against own recommendations
Alkermes plc.
- Shareholders approved 2018 Stock Option and Incentive Plan amendment, adding 6,500,000 shares.
- All 6 management director nominees re-elected; dissident Sarissa withheld votes despite prior recommendation.
- All company proposals passed: say-on-pay (115.9M for), auditor (142.6M for), share issuance authority.
- Sarissa cast over 13 million votes contrary to its stated voting intent on plan, issuance, and pre-emption items.
- Equity plan approval received 125.4M votes for and 21.3M against, including Sarissa's 13M+ no votes.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Alkermes plc. shareholders approved Advisory vote on executive compensation at the 2023-06-29 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2023-06-29
Exact text from the filing
2. Shareholders approved, in a non-binding, advisory vote, the compensation of the Company’s named executive officers, with the votes cast as follows: 115,881,199 votes for; 30,815,867 * votes against; and 289,712 votes abstaining.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Alkermes plc. shareholders approved Renewal of Board authority to disapply statutory pre-emption rights under Irish law at the 2023-06-29 meeting.
- Outcome
- passed
- Meeting
- 2023-06-29
Exact text from the filing
6. Shareholders renewed Board authority to disapply the statutory pre-emption rights that would otherwise apply under Irish law, with the votes cast as follows: 111,942,236 votes for; 34,750,182 ** votes against; and 294,360 votes abstaining.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Alkermes plc. shareholders approved Renewal of Board authority to allot and issue shares under Irish law at the 2023-06-29 meeting.
- Outcome
- passed
- Meeting
- 2023-06-29
Exact text from the filing
5. Shareholders renewed Board authority to allot and issue shares under Irish law, with the votes cast as follows: 131,189,831 votes for; 15,574,774 ** votes against; and 222,173 votes abstaining.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Alkermes plc. shareholders approved Approval of the 2018 Plan (equity incentive plan) at the 2023-06-29 meeting.
- Proposal
- equity plan
- Outcome
- passed
- Meeting
- 2023-06-29
Exact text from the filing
4. Shareholders approved the 2018 Plan, with the votes cast as follows: 125,407,407 votes for; 21,308,908 ** votes against; and 270,463 votes abstaining.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Alkermes plc. shareholders approved Re-election of directors for a one-year term expiring at the 2024 annual general meeting at the 2023-06-29 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2023-06-29
Exact text from the filing
On June 29, 2023, the Company held its Annual Meeting. Based on the certified voting report provided by the inspector of elections for the Annual Meeting, the final voting results are as follows: 1. Shareholders re-elected the following directors, each to serve as a director for a one-year term expiring at the Company’s 2024 annual general meeting of shareholders or until their respective successor is elected and shall qualify, with the votes cast as follows: For: Withheld: Emily Peterson Alva 133,264,886 13,721,892 ** Shane M. Cooke 109,649,902 37,336,876 * Richard B. Gaynor, M.D. 85,056,971 61,929,807 * Cato T. Laurencin, M.D., Ph.D. 132,349,967 14,636,811 ** Brian P. McKeon 133,130,612 13,856,166 ** Richard F. Pops 107,961,225 39,025,553 * Christopher I. Wright, M.D., Ph.D. 132,681,062 14,305,716 **
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Alkermes plc. shareholders approved Ratification of PricewaterhouseCoopers LLP as independent auditor and authorization of Audit and Risk Committee to set remuneration at the 2023-06-29 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2023-06-29
Exact text from the filing
3. Shareholders ratified, in a non-binding vote, the appointment of PricewaterhouseCoopers LLP as the independent auditor and accounting firm of the Company, and authorized, in a binding vote, the Audit and Risk Committee of the Board of Directors of the Company (the “Board”) to set the independent auditor and accounting firm’s remuneration, with the votes cast as follows: 142,558,190 votes for; 4,308,181 votes against; and 120,407 votes abstaining.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.